Diabetes Market Research Reports & Industry Analysis
Glucose monitors have a major consumer-marketing component. While physicians may prescribe a monitor, the patient ultimately has the choice of which monitor s/he uses. Insulin provides very little consumer choice. The treatment regimen prescribed by the physician must be followed and there are very few market options. With Eli Lilly and Novo Nordisk being the two largest producers of insulin, it is highly likely that an insulin user will wind up using one of their products. As time goes by, the options of oral insulin and more intranasal insulin products may offer insulin dependent diabetics more variety in terms of products and delivery methods.
Hypoglycemic agents abound and vary in their composition and mode of action. For the most part, advanced cases of Type 2 diabetes require more than one of these drugs in order for the patient to maintain glycemic control. Because of the wide variety of these products, there is some room for pharmaceutical companies to influence diabetics toward using their products. In the end, the physician may have the last word, but that does not mean that the patient will stay with a physician who does not acquiesce to his/her wishes.
Diabetes Industry Research & Market Reports
-
Wearable Healthcare Devices Market Analysis and Forecast to 2032: By Device (Activity/Fitness Monitors, Diabetes Devices, Cardiac Monitors, Neurological Monitors, Respiratory Monitors, Body & Temperature Monitors, Hearing Aids), By Application (Cardiac Health, Obesity Control, Diabetes Care, Fitness Monitoring, Sleep Tracking), By End-use (Home Healthcare, Remote Patient Monitoring, Fitness and Sports), and Region
... Fitness Monitoring, Sleep Tracking), By End-use (Home Healthcare, Remote Patient Monitoring, Fitness and Sports), and Region The global wearable healthcare devices market was valued at USD 14.3 billion in 2022 and it is anticipated to ... Read More
-
Insulin Pumps Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... 7.2 Billion by 2028, exhibiting a growth rate (CAGR) of 6.1% during 2023-2028. Insulin pumps are small computerized medical devices that can be clipped on to a belt, pocket or hidden under the clothes. The ... Read More
-
Artificial Pancreas Device Systems (APDS) Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... expects the market to reach US$ 4,500.6 Million by 2028, exhibiting a growth rate (CAGR) of 11.8% during 2023-2028. APDS refers to a closed-loop or automated insulin delivery system that manages blood glucose levels by ... Read More
-
Autoinjectors Market (Type: Disposable and Reusable; Technology: Handheld and Wearable; Indication: Multiple Sclerosis, Rheumatoid Arthritis, Diabetes, Anaphylaxis, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
... Report TMR’s report on the global Autoinjectors Market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from ... Read More
-
Autoinjectors Market by Usage (Reusable, Disposable), Technology (Manual, Automatic), Therapy (Rheumatoid Arthritis, Diabetes, Anaphylaxis), Route of administration (SC, IM), Volume (<3ml, >3ml), End User (Home Care, Hospitals) - Global Forecast to 2028
... devices market is projected to reach USD 1.7 billion in 2028 from USD 0.9 billion in 2023, growing at a CAGR of 14.0%. Where as, the autoinjector finished formulations market is projected to reach USD ... Read More
-
Digital Marketing Trends in Type 2 Diabetes
... Eli Lilly's Trulicity.com and AstraZeneca's Farxiga.com. The highest proportion of traffic to branded patient T2D websites originated from direct sources, followed by organic. Novo Nordisk’s Rybelsus.com had the highest proportion of direct traffic. Mounjaro.com was ... Read More
-
B-Ketone Monitoring System Market: By Product Type (Disposable, Reusable, Other), By End User (Hospital, Homecare, Diagnostic Laboratories, Special Clinics), And Region – Global Analysis of Market Size, Share & Trends For 2021–2022 And Forecasts To 2032
... 2032 B-Ketone Monitoring System Market: By Product Type (Disposable, Reusable, Other), By End User (Hospital, Homecare, Diagnostic Laboratories, Special Clinics), And Region – Global Analysis of Market Size, Share & Trends For 2021–2022 And Forecasts ... Read More
-
Geriatric Care Services Market: By Type (Home-care, Health-care, Institutional care centers, Non-medical health care, Hospital based care, Assisted living, Independent senior living, Rehabilitative care services), By Application (Respiratory Diseases, Diabetes, Osteoporosis, Heart Diseases, Others), By Age Group (65-70 Years, 71-75 Years, 76-80 Years, 81-85 Years, 86-90 Years, Above 91 Years), By Payment Source (Public Insurance, Private Insurance, Out-of-pocket), By End user (Institutional Care Services, Nursing Homes, Rehabilitation Centers, Hospitals) And Region – Global Analysis of Market Size, Share & Trends For 2021–2022 And Forecasts To 2032
... Age Group (65-70 Years, 71-75 Years, 76-80 Years, 81-85 Years, 86-90 Years, Above 91 Years), By Payment Source (Public Insurance, Private Insurance, Out-of-pocket), By End user (Institutional Care Services, Nursing Homes, Rehabilitation Centers, Hospitals) And ... Read More
-
Global Metabolic Syndrome Market (2023 Edition): Analysis By Indication (NASH, IRS, Hypercholesterolemia, Obesity Syndrome, Others), By Molecule Type, Route of Administration, By Region, By Country: Market Insights and Forecast (2018-2028)
... released a research report titled “Metabolic Syndrome Market (2023 Edition)” which provides a complete analysis of the global Metabolic Syndrome industry in terms of market segmentation By Indication (Insulin Resistance Syndrome, Hypercholesterolemia, Obesity Syndrome, Nonalcoholic ... Read More
-
Home Healthcare Market Size, Share & Trends Analysis Report By Component (Equipment, Services), By Indication (Cardiovascular Disorder & Hypertension, Diabetes & Kidney Disorders), By Region, And Segment Forecasts, 2023 - 2030
... 7.96% over the forecast period. This growth can be attributed to cost-efficiency, improved patient outcomes, and convenience offered by home healthcare agencies. In addition, the rising geriatric population and the growing prevalence of chronic diseases ... Read More
-
India Digital Diabetes Management Market, By Product (Smart Glucose Meter, Continuous Blood Glucose Monitoring System, Smart Insulin Pens, Smart Insulin Pumps, Apps); By Device (Wearable Devices, Handheld Devices); By End Use (Hospitals, Home Settings, Diagnostic Centers); By Region (North India, South India, East India, West India), Trend Analysis, Competitive Landscape & Forecast, 2019–2029
... Centers); By Region (North India, South India, East India, West India), Trend Analysis, Competitive Landscape & Forecast, 2019–2029 India Digital Diabetes Management Market Size More Than Doubles to Reach USD 1.1 Billion by 2029 The ... Read More
-
Metabolic Disorders Drugs Market Covering Anti Diabetics drugs; Anti-Thyroid drugs; Antiobesity; Others (Hypopituitarism, Hypoadrenalism); Global Summary 2023
... the market accounting for 5.7%. In terms of per capita consumption, the market was $11.7 and in terms of global GDP, the market was 0.08%. Metabolic disorders drugs was the seventh largest segment within the ... Read More
-
Diabetic Macular Edema Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
... Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update provides an overview of Diabetic Macular Edema Clinical trials scenario. This report provides top line data relating to the ... Read More
-
Indian Diabetes Market Report: Patients, Prevalence, Oral Antidiabetics, Insulin and Diagnostics
... 2028, exhibiting a growth rate (CAGR) of 16% during 2023-2028. The Indian population that had faced under nutrition for a long time is now exposed to over nutrition and sedentary lifestyles. Coupled with a bad ... Read More
-
Non-Alcoholic Steatohepatitis (NASH) Market by Drug Type (Vitamin E and Pioglitazone, Ocaliva, Elafibranor, Selonsertib, Cenicriviroc, and Others), Disease Cause (Hypertension, Heart Disease, High Blood Lipid, Type 2 Diabetes, Obesity), Sales Channel (Hos
... Retail Pharmacy), End User (Hospitals, Clinics, Homecare Settings), and Region 2023-2028 Market Overview: The global non-alcoholic steatohepatitis (NASH) market size reached US$ 1.21 Billion in 2022. Looking forward, IMARC Group expects the market to reach ... Read More
-
Global Diabetic Foot Ulcer Market - 2023-2030
... by 2030. The diabetic foot ulcers market is expected to exhibit a CAGR of 6.2% during the forecast period (2023-2030). Diabetic foot ulcers are one of the most prevalent consequences in persons with poorly managed ... Read More
-
Diabetes Assays Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update
... and Countries, Regulatory Path and Key Companies, 2023 Update provides comprehensive information about the Diabetes Assays pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials ... Read More
-
Global Diabetic Shoes Market Report and Forecast 2023-2031
... awareness about the importance of foot care in diabetes management across the globe. The market size is anticipated to grow at a CAGR of 8% during the forecast period of 2023-2031 to achieve a value ... Read More
-
GLP-1 Receptor Agonist Market - By Drug Class (Semaglutide, Dulaglutide, Liraglutide, Exenatide), By Route of Administration (Parenteral), By Application (Type 2 Diabetes, Obesity), By Distribution (Hospital, Retail), Global Forecast, 2023 - 2032
... Market is poised to witness significant growth from 2023 to 2032 owing to the high prevalence of diabetes and increasing patient awareness about the benefits of using GLP-1 receptor agonists. GLP-1 receptor agonists work by ... Read More
-
The World Market for Medicaments Containing Insulin Excluding Those in Dosage Form or Retail Packings: A 2024 Global Trade Perspective
... with the market for medicaments containing insulin excluding those in dosage form or retail packings. With the globalization of this market, managers can no longer be contented with a local view. Nor can managers be ... Read More
-
The World Market for Insulin and Its Salts: A 2024 Global Trade Perspective
... salts. With the globalization of this market, managers can no longer be contented with a local view. Nor can managers be contented with out-of-date statistics that appear several years after the fact. Professor Philip M. ... Read More
-
The World Market for Medicaments Containing Insulin in Dosage Form or Retail Packings: A 2024 Global Trade Perspective
... market for medicaments containing insulin in dosage form or retail packings. With the globalization of this market, managers can no longer be contented with a local view. Nor can managers be contented with out-of-date statistics ... Read More
-
Global Chronic Disease Management Therapeutics and Device Technologies Market Size study & Forecast, by Disease (Cardiovascular diseases (CVD), Diabetes, Cancer, Chronic respiratory diseases, Chronic kidney diseases, Neurological disorders, Others (such as autoimmune diseases, gastrointestinal disorders, and many)) by Therapy (Medications, Rehabilitation therapy, Behavioral therapy, Others (such as gene therapy, stem cell therapy, and many)), by Device (Blood glucose monitoring devices, Blood pressure monitors, Cardiac monitors, Respiratory therapy devices, Kidney dialysis machines, Neurostimulation devices, Others (such as insulin pumps, continuous glucose monitoring devices, and many)) and Regional Analysis, 2023-2030
... and many)) by Therapy (Medications, Rehabilitation therapy, Behavioral therapy, Others (such as gene therapy, stem cell therapy, and many)), by Device (Blood glucose monitoring devices, Blood pressure monitors, Cardiac monitors, Respiratory therapy devices, Kidney dialysis ... Read More
-
Direct-to-consumer (DTC) Laboratory Testing Market by Application (Genetic Testing {Ancestry, Carrier Status, Disease Risk [Cancer, Neurological, Cardiac]}, Diabetes, COVID, STD, Routine, CBC), Sample Type (Saliva, Urine, Blood)—Global Forecast to 2030
... by Application (Genetic Testing {Ancestry, Carrier Status, Disease Risk [Cancer, Neurological, Cardiac]}, Diabetes, COVID, STD, Routine, CBC), Sample Type (Saliva, Urine, Blood)—Global Forecast to 2030 The global DTC laboratory testing market is projected to reach ... Read More
-
2023 Global Forecast for Insulin Delivery Devices Market (2024-2029 Outlook)-High Tech & Emerging Markets Report
... countries. The product or service category is within the NAICS Medical Device Mfg. industry. The product or service category is within the NAICS Medical Device Mfg. industry. The global market is expected to increase from ... Read More
Research Assistance
